Literature DB >> 8728435

Change in paternity: a risk factor for preeclampsia in multiparas.

L S Trupin1, L P Simon, B Eskenazi.   

Abstract

Preeclampsia, a hypertensive disorder of pregnancy, is hypothesized to be a maternal immunologic response to foreign fetal antigen derived from the father's sperm. This response may be reduced by prolonged exposure to father's antigen, such as through a prior pregnancy, which may explain why multiparas are typically at lower risk for preeclampsia than nulliparas. Since multiparas with new partners are presented with a new set of paternal antigen, we hypothesize that they would have the same elevated risk for preeclampsia and gestational hypertension as nulliparas, compared with multiparas with no change in partner. We studied 5,068 nulliparas and 5,800 multiparas, 573 of whom had new partners, selected from the Child Health and Development Studies cohort (Oakland, CA, 1959-1967). Preeclampsia was diagnosed in 3.2% of nulliparas, 3.0% of multiparas with changed paternity, and 1.9% of multiparas with no change. Compared with multiparas with no change, the adjusted odds ratio for preeclampsia among nulliparas was 2.5 [95% confidence interval (CI) = 1.8-3.5]; among multiparas with new partners, the adjusted odds ratio for preeclampsia was 1.4 (95% CI = 0.8-2.4). There was a similar pattern of results for gestational hypertension. The adjusted attributable risk of preeclampsia in multiparas associated with a change in paternity was 29%. Although these findings in part support the immunologic theory of preeclampsia, they also suggest that a subsequent pregnancy with any partner is associated with a reduced risk for preeclampsia.

Entities:  

Mesh:

Year:  1996        PMID: 8728435     DOI: 10.1097/00001648-199605000-00004

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  24 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Preeclampsia: theories and speculations.

Authors:  Jeffrey C Livingston; Bryan D Maxwell
Journal:  Wien Klin Wochenschr       Date:  2003-03-31       Impact factor: 1.704

3.  Fetal and maternal contributions to risk of pre-eclampsia: population based study.

Authors:  R T Lie; S Rasmussen; H Brunborg; H K Gjessing; E Lie-Nielsen; L M Irgens
Journal:  BMJ       Date:  1998-05-02

4.  Pregnancy-induced maternal regulatory T cells, bona fide memory or maintenance by antigenic reminder from fetal cell microchimerism?

Authors:  Jeremy M Kinder; Tony T Jiang; Dayna R Clark; Vandana Chaturvedi; Lijun Xin; James M Ertelt; Sing Sing Way
Journal:  Chimerism       Date:  2014-02-19

5.  Prediction and prevention of hypertensive disorders of pregnancy.

Authors:  Akihide Ohkuchi; Chikako Hirashima; Kayo Takahashi; Hirotada Suzuki; Shigeki Matsubara
Journal:  Hypertens Res       Date:  2016-08-18       Impact factor: 3.872

Review 6.  Regulatory T cell memory.

Authors:  Michael D Rosenblum; Sing Sing Way; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2015-12-21       Impact factor: 53.106

Review 7.  Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  World J Nephrol       Date:  2014-11-06

8.  Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study.

Authors:  A Conde-Agudelo; J M Belizán
Journal:  BMJ       Date:  2000-11-18

9.  Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia.

Authors:  Y Sasaki; D Darmochwal-Kolarz; D Suzuki; M Sakai; M Ito; T Shima; A Shiozaki; J Rolinski; S Saito
Journal:  Clin Exp Immunol       Date:  2007-04-25       Impact factor: 4.330

10.  Cross-Generational Reproductive Fitness Enforced by Microchimeric Maternal Cells.

Authors:  Jeremy M Kinder; Tony T Jiang; James M Ertelt; Lijun Xin; Beverly S Strong; Aimen F Shaaban; Sing Sing Way
Journal:  Cell       Date:  2015-07-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.